Mathematics
Lung Cancer
86%
Competing Risks
77%
Progression
73%
Toxicity
65%
Chemotherapy
50%
Cell
46%
Utility Function
29%
Line
25%
Design
23%
Performance Test
19%
Posterior Mean
16%
Randomized Clinical Trial
16%
Misspecification
14%
Bayesian Model
14%
Comparative Study
14%
Treatment Effects
13%
Justify
12%
Exponential distribution
12%
Continue
10%
Evaluate
10%
Simulation Study
9%
Simulation
7%
Business & Economics
Lung Cancer
100%
Competing Risks
86%
Progression
62%
Chemotherapy
60%
Toxicity
59%
Utility Function
22%
Comparative Tests
20%
Bayesian Model
18%
Exponential Distribution
15%
Clinical Trials
15%
Misspecification
14%
Treatment Effects
14%
Simulation Study
12%
Efficacy
11%
Comparative Study
11%
Physicians
9%
Simulation
8%
Performance
4%